Clinical Edge Journal Scan

Weight loss after bariatric surgery may reduce risk of developing breast cancer


 

Key clinical point: Weight loss after bariatric surgery reduced the risk of developing breast cancer (BC) in women with prior obesity to a level equivalent to that in women with a body mass index (BMI) of <25 kg/m2.

Major finding: After a 1-year washout period, women who did vs did not undergo bariatric surgery had significantly reduced BC risk (hazard ratio [HR] 1.40; P < .001), equivalent to that in women with BMI <25 kg/m2 (HR 1.07; P = .10). Weight loss after bariatric surgery was associated with reduced BC risk at 2- and 5-year washout periods as well (both P < .001).

Study details: Findings are from a population-based, multiple cohort study including 13,852 women with obesity who underwent bariatric surgery and 55,408 age- and BC screening status-matched women with no history of bariatric surgery, of which 659 women were diagnosed BC.

Disclosures: This study was supported by the Ontario Bariatric Registry, Canada, and ICES, Canada. The authors declared no conflicts of interest.

Source: Doumouras AG et al. Residual risk of breast cancer after bariatric surgery. JAMA Surg. 2023 (Apr 12). Doi: 10.1001/jamasurg.2023.0530

Recommended Reading

Preoperative breast MRI has no impact on survival in breast cancer
Breast Cancer ICYMI
No increase in mortality risk with estrogen therapy in HR+ BC
Breast Cancer ICYMI
Longer interval between surgery and ET worsens survival outcomes in HR+ BC
Breast Cancer ICYMI
Meta-analysis demonstrates high hypothyroidism risk in BC survivors
Breast Cancer ICYMI
Dietary Inflammatory Index and BC risk: Is there a link?
Breast Cancer ICYMI
Commentary: Alisertib, trastuzumab, and treatment timing, April 2023
Breast Cancer ICYMI
Breast conservation safe even with multiple-site tumors
Breast Cancer ICYMI
De-escalation still beneficial after 10 years for some HER2+ breast cancers
Breast Cancer ICYMI
Survival improved for some patients with metastatic cancers
Breast Cancer ICYMI
Outpatient costs top drug costs in some insured, working women with breast cancer
Breast Cancer ICYMI